Theriva Biologics, Inc. (TOVX) Revenue History
Annual and quarterly revenue from 1993 to present
TOVX Revenue Over Time (1993–2025)
TOVX Revenue Growth History
4 of 12 years with positive growth- FY1993 revenue growth
- N/A
- FY1994 revenue growth
- +0.0%
- FY1995 revenue growth
- +0.0%
- FY1996 revenue growth
- +400.0%
- FY1997 revenue growth
- +0.0%
- FY1998 revenue growth
- -20.0%
- FY1999 revenue growth
- -0.2%
- FY2000 revenue growth
- +26.8%
- FY2001 revenue growth
- +72.6%
- FY2002 revenue growth
- -98.9%
- FY2005 revenue growth
- -100.0%
- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- N/A
- FY2009 revenue growth
- N/A
- FY2010 revenue growth
- +2969.7%
- FY2011 revenue growth
- -100.0%
- FY2012 revenue growth
- N/A
- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $300K | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
TOVX Revenue Analysis (1993–2025)
Current Revenue & Growth
As of June 22, 2026, Theriva Biologics, Inc. (TOVX) generated trailing twelve-month (TTM) revenue of $300,000. The most recent quarter (Q1 2026) recorded $300,000 in revenue
Historical Growth Trajectory
TOVX's historical revenue data shows various trends over time. Theriva Biologics, Inc.'s highest annual revenue of $3.2 million was recorded in 2010.
Peer Comparison
Compared to Healthcare sector peers — including NKTR (-36.2% YoY), AGEN (+24.5% YoY), and IMMP (+54.3% YoY). Compare TOVX vs NKTR →
TOVX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TOVXCurrent | $300,000 | - | - | - | |
 NKTR | $55M | -36.2% | -18.4% | -236.8% | |
 AGEN | $114M | +24.5% | +5.3% | -18.0% | |
 IMMP | $5M | +54.3% | -7.6% | -2506.5% |
TOVX Historical Revenue Data (1993–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-108,000 | - | $-15,020,000 | - |
| 2024 | $0 | - | $0 | - | $-26,346,000 | - |
| 2023 | $0 | - | $0 | - | $-21,431,000 | - |
| 2022 | $0 | - | $0 | - | $-21,581,000 | - |
| 2021 | $0 | - | $0 | - | $-14,274,000 | - |
| 2020 | $0 | - | $0 | - | $-10,160,000 | - |
| 2019 | $0 | - | $0 | - | $-15,663,000 | - |
| 2018 | $0 | - | $-272,000 | - | $-17,571,000 | - |
| 2017 | $0 | - | $-245,000 | - | $-26,251,000 | - |
| 2016 | $0 | - | $-157,000 | - | $-39,252,000 | - |
| 2015 | $0 | - | $-72,000 | - | $-40,980,000 | - |
| 2014 | $0 | - | $0 | - | $-20,502,000 | - |
| 2013 | $0 | - | $0 | - | $-12,339,000 | - |
| 2012 | $0 | - | $0 | - | $-17,299,000 | - |
| 2011 | $0 | -100.0% | $0 | - | $-5,928,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TOVX — Frequently Asked Questions
Quick answers to the most common questions about buying TOVX stock.
Is TOVX's revenue growth accelerating or slowing?
TOVX TTM revenue: $300000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TOVX's revenue history from 1993 to 2026?
Theriva Biologics, Inc. (TOVX) revenue history spans 1993 to 2026. TTM revenue as of 2026 is $300000.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is TOVX's long-term revenue growth rate (CAGR)?
Theriva Biologics, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for TOVX.
Why does TOVX's quarterly revenue fluctuate?
TOVX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Theriva Biologics, Inc.'s revenue data from 1993 to 2026 shows full historical quarterly detail on this page.
How is TOVX's revenue distributed by segment?
TOVX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does TOVX's revenue compare to industry peers?
Theriva Biologics, Inc. (TOVX) with TTM revenue of $300000.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.